Gestofit 200 Capsule contains Progesterone 200mg, a naturally occurring steroid hormone essential for the regulation of the menstrual cycle and maintenance of pregnancy. It is primarily indicated for the treatment of progesterone deficiency, which may manifest as irregular menstrual cycles, luteal phase insufficiency, or amenorrhea. Additionally, Gestofit 200 is used in assisted reproductive technology protocols to support the luteal phase and improve implantation rates. Progesterone plays a critical role in preparing the endometrium for embryo implantation and sustaining early pregnancy by modulating the immune response and preventing uterine contractions. This formulation is administered orally and is absorbed through the gastrointestinal tract, undergoing hepatic metabolism. Common clinical applications include hormone replacement therapy in menopausal women, management of abnormal uterine bleeding, and prevention of preterm birth in high-risk pregnancies. The dosage and duration of treatment should be individualized based on the patient’s clinical condition and response to therapy. Contraindications include known hypersensitivity to progesterone or any component of the capsule, undiagnosed vaginal bleeding, and active thromboembolic disorders. Patients should be monitored for potential side effects such as dizziness, headache, breast tenderness, and gastrointestinal disturbances. Gestofit 200 Capsule should be used under strict medical supervision to ensure safety and efficacy.